Entrada Therapeutics (TRDA) Accumulated Expenses (2020 - 2026)
Entrada Therapeutics' Accumulated Expenses came in at $13 million for Q2 2026, up 10.2% from $11.8 million a year earlier and up 10.9% from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Accumulated Expenses (2020 - 2026) Analysis & Trends
At the end of FY2025, Entrada Therapeutics' Accumulated Expenses was $17.68 million, up 32.5% from FY2024.
- Accumulated Expenses has increased in each of the last five years, with a five-year compound annual growth rate of 58.7% (FY2020 to FY2025).
- Going back by year, Accumulated Expenses was $13.34 million in FY2024 (+17.8%), $11.33 million in FY2023 (+49.5%), $7.58 million in FY2022 (+26.0%) and $6.01 million in FY2021 (+242.2%).
- The five-year range for quarterly Accumulated Expenses is $4.52 million (Q1 2022) to $17.68 million (Q4 2025).
- Year-over-year, Accumulated Expenses has increased for five consecutive quarters, with growth averaging 20.5% over the last eight quarters.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q4 2021 (growth of 242.2%), and the weakest in Q1 2024 (a decline of 24.7%).
- Business Quant data shows TRDA's Accumulated Expenses at $11.73 million (Q1 2026), $17.68 million (Q4 2025) and $15.53 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Entrada Therapeutics | 205.54 Mn | -172.82 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.28 Mn |
| Jun 30, 2026 | 13.00 Mn |
| Mar 31, 2026 | 11.73 Mn |
| Dec 31, 2025 | 17.68 Mn |
| Sep 30, 2025 | 15.53 Mn |
| Jun 30, 2025 | 11.80 Mn |
| Mar 31, 2025 | 7.58 Mn |
| Dec 31, 2024 | 13.34 Mn |
| Sep 30, 2024 | 13.40 Mn |
| Jun 30, 2024 | 11.00 Mn |
| Mar 31, 2024 | 8.79 Mn |
| Dec 31, 2023 | 11.33 Mn |
| Sep 30, 2023 | 9.60 Mn |
| Jun 30, 2023 | 7.11 Mn |
| Mar 31, 2023 | 11.68 Mn |
| Dec 31, 2022 | 7.58 Mn |
| Sep 30, 2022 | 11.95 Mn |
| Jun 30, 2022 | 5.34 Mn |
| Mar 31, 2022 | 4.52 Mn |
| Dec 31, 2021 | 6.01 Mn |
API Access
Entrada Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();